Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Woman's
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Karen Elkind-Hirsch, Woman's Identifier:
First received: May 14, 2013
Last updated: July 11, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)